QCLS - MyMD Pharmaceuticals, Inc.
4.5
1.020 22.667%
Share volume: 10,947,143
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.48
1.02
0.29%
Summary score
39%
Profitability
35%
Dept financing
42%
Liquidity
11%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-22.93%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
58.32%
Debt ratio change over timeo
0%
Current Ratio
1.47%
Quick Ratio
0%
Cash Position Ratio
0.24%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-8.26%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
62.16%
Debt ratio change over timeo
0%
Current Ratio
1.34%
Quick Ratio
0%
Cash Position Ratio
0.37%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-7.65%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
61.93%
Debt ratio change over time
0%
Current Ratio
1.71%
Quick Ratio
0%
Cash Position Ratio
1.06%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | QCLS | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 0% | 26.16% | 4.24% | 17.49% |
| Return on assets | -22.93% | 9% | 4.07% | 17.99% |
| Return on sales | 0% | 29.06% | 18.16% | 61.3% |
| Return on invested capital | 0% | 33.06% | 9.11% | 71.15% |
| Profitability | 0% | 61% | 20% | 92% |
| Total debt ratio | 58.32% | 63.06% | 49.7% | 21.27% |
| Debt ratio change over time | 0% | 1.34% | -8.26% | -0.43% |
| Dept financing | 23% | 50% | 20% | 8% |
| Current Ratio | 1.34% | 1.19% | 4.55% | 0% |
| Quick Ratio | 0% | 0.86% | 4.31% | 0% |
| Cash Position Ratio | 0.37% | 0.18% | 2.79% | 0% |
| Liquididy | 11% | 15% | 64% | 75% |
| Short-term ratios | QCLS | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -8.26% | 9.87% | 4.6% | 0% |
| Return on sales | 0% | 31.21% | 22.78% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 30% | 0% |
| Total debt ratio | 62.16% | 54.15% | 46.03% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 22% | 19% | 0% |
| Current Ratio | 1.34% | 1.19% | 4.55% | 0% |
| Quick Ratio | 0% | 0.86% | 4.31% | 0% |
| Cash Position Ratio | 0.37% | 0.18% | 2.79% | 0% |
| Liquididy | 11% | 13% | 75% | 0% |